化合物、組成物および方法 - Cytokinetics Incorporated

Title:

化合物、組成物および方法

Document Type and Number:

Japanese Patent JP2009519939

Kind Code:

A

Abstract:

Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.

More Like This:

JP2008525419	HIV-1 reverse transcriptase non-nucleoside inhibitor
JP2000514061	INDUSTRIAL APPLICABILITY [Title of Invention] Fibrinogen Receptor Antagonist
WO/1995/004034	(THIO)CARBIMIDINIC ACID DERIVATIVES AND MEDICAMENTS CONTAINING THE SAME

Inventors:

Morgan, Bradley, Pee.
Morgans, David Jay., Junior
Whip, Alex
Liu Pu-pin
Claynac, Erica
Tochimoto, Todd

Application Number:

JP2008545811A

Publication Date:

May 21, 2009

Filing Date:

December 14, 2006

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Cytokinetics Incorporated

International Classes:

C07D213/75; A61K31/496; A61P9/04; A61P43/00; C07D261/14

Domestic Patent References:

JP2000515150A	2000-11-14
JPH07188151A	1995-07-25
JP2000515150A	2000-11-14
JPH07188151A	1995-07-25

Foreign References:

WO2004064730A2	2004-08-05
US20030008868A1	2003-01-09
US6583282B1	2003-06-24
WO2004064730A2	2004-08-05
US20030008868A1	2003-01-09
US6583282B1	2003-06-24

Attorney, Agent or Firm:

Yusuke Hiraki
Ishii Teiji
Satoshi Fujita

Previous Patent: （Ｒ）−トフィソパムを単離する方法

Next Patent: 皮膚科学的状態を処置するための組成物および方法